1072 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Ilson
    Ilson
  4. Rusch
    Rusch
  5. Miller
    Miller
  6. Kelsen
    Kelsen
  7. Krug
    Krug
  8. Hellmann
    Hellmann
  9. Bains
    Bains
  10. Travis
    Travis

Groups

  1. Solid Tumor Oncology Division (1072)
  2. Thoracic Malignancies Disease Management Team (1072)
  3. Thoracic Oncology Service (700)
  4. Thoracic Oncology (381)
  5. Gastrointestinal Oncology Service (340)
  6. Thoracic Oncology (304)
  7. Surgery (239)
  8. Gastrointestinal Disease Management Team (207)
  9. Colorectal Disease Management Team (197)
  10. Epidemiology and Biostatistics (153)
Refine Results
  1. "Thoracic Malignancies Disease Management Team"
  2. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (607)
  2. Meeting Abstract (414)
  3. Book Section (35)
  4. Conference Paper (14)
  5. Book Whole (2)
Groups
  1. Solid Tumor Oncology Division (1072)
  2. Thoracic Malignancies Disease Management Team (1072)
  3. Thoracic Oncology Service (700)
  4. Thoracic Oncology (381)
  5. Gastrointestinal Oncology Service (340)
  6. Thoracic Oncology (304)

More Groups

People
  1. Mark Kris (289)
  2. David Ilson (221)
  3. Gregory Riely (161)
  4. Matthew Hellmann (98)
  5. David Kelsen (92)
  6. Valerie Rusch (92)

More People

Years
  1. 2019 (66)
  2. 2018 (96)
  3. 2017 (116)
  4. 2016 (76)
  5. 2015 (96)
  6. 2014 (84)

More Years

Publications
  1. Journal of Clinical Oncology (236)
  2. Journal of Thoracic Oncology (116)
  3. Annals of Oncology (51)
  4. Clinical Cancer Research (39)
  5. International Journal of Radiation Oncology, Biology, Physics (36)
  6. Cancer (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (251)
  2. Elsevier Inc. (237)
  3. Oxford University Press (74)
  4. American Association for Cancer Research (66)
  5. Springer (43)
  6. Wiley Blackwell (42)

More Publishers

Results (1072)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001
    Meeting Abstract

    Garon, E. B.; Hellmann, M. D.; Costa, E. C.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pooled safety analysis from phase 3 studies of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC) and metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Van Cutsem, E.; Hochster, H. S.; Shitara, K.; Mayer, R. J.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H. T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer
    Meeting Abstract

    Skoulidis, F.; Arbour, K. C.; Hellmann, M. D.; Patil, P. D.; Marmarelis, M. E.; Awad, M. M.; Murray, J. C.; Hellyer, J.; Gainor, J. F.; Dimou, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged >= 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Shitara, K.; Doi, T.; Hosaka, H.; Thuss-Patience, P. C.; Santoro, A.; Jimenez-Fonseca, P.; Longo, F.; Ozyilkan, O.; Cicin, I.; Park, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: Integrated analysis from three clinical trials
    Meeting Abstract

    Siena, S.; Doebele, R. C.; Shaw, A. T.; Karapetis, C. S.; Tan, D. S. W.; Cho, B. C.; Kim, D. W.; Ahn, M. J.; Krebs, M.; Goto, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • TMB standardization by alignment to reference standards: Phase II of the Friends of Cancer Research TMB Harmonization Project
    Meeting Abstract

    Merino, D. M.; McShane, L.; Butler, M.; Funari, V. A.; Hellmann, M. D.; Chaudhary, R.; Chen, S. J.; Chen, W. S.; Conroy, J. M.; Fabrizio, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Mansoor, W.; Arkenau, H. T.; Alsina, M.; Shitara, K.; Tejani, M. A.; Thuss-Patience, P. C.; Cuffe, S.; Dvorkin, M.; Park, D.; Ando, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib
    Meeting Abstract

    Kummar, S.; Mascarenhas, L.; Geoerger, B.; Turpin, B.; Cox, M. C.; Yu, S.; Nanda, S.; Hiemeyer, F.; Keating, K. N.; Chirila, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3)
    Meeting Abstract

    Kwiatkowski, D. J.; Rusch, V. W.; Chaft, J. E.; Johnson, B. E.; Nicholas, A.; Wistuba, I. I.; Merritt, R.; Lee, J. M.; Bunn, P. A.; Tang, Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in adult TRK fusion cancer patients
    Meeting Abstract

    Hong, D. S.; Kummar, S.; Farago, A. F.; Lassen, U. N.; Berlin, J.; Schilder, R. J.; McDermott, R. S.; Patel, J. D.; Dowlati, A.; Doebele, R. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save